Status:
COMPLETED
Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if telecare using modern telecommunication devices can improve the metabolic control and the quality of life of type 1 diabetic patients.
Detailed Description
We aim at comparing conventional follow-up of type 1 diabetic patients treated with continuous subcutaneous insulin infusion (CSII) (face-to-face visits) with an intensive coaching using the Web and t...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus
- Age ≥ 18
- HbA1c between 7.5 and 10%
- Treated with continuous subcutaneous insulin infusion for a minimum of 3 months
Exclusion
- Unstabilized diabetic microangiopathy
- Ongoing pregnancy or planned pregnancy
- Unwilling to perform a minimum of 4 capillary blood tests per day
- Unable to use the GlucoNet device
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00324584
Start Date
April 1 2003
End Date
September 1 2004
Last Update
July 7 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Department of Endocrinology
Grenoble, France, 38043
2
University Hospital, Department of Endocrinology
Toulouse, France, 31000